Navigating resistance in global health governance: Certification of smallpox eradication in China

Certification is an essential stage in disease eradication efforts, encompassing epidemiological, managerial, and political complexities. The certification of smallpox eradication in the People's Republic of China (PRC, or China) exemplifies the multifaceted nature of the certification. Despite...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Global public health Ročník 19; číslo 1; s. 2326011
Hlavní autor: Chen, Lu
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Taylor & Francis 2024
Taylor & Francis Ltd
Taylor & Francis Group
Témata:
Certification
China
Coronaviruses
COVID-19
Credibility
Disease
Disease Eradication
Epidemiology
Eradication
Global Health
global health politics
Governance
Health
Humans
Pandemics
Public health
Resistance
Resistance factors
Smallpox
Smallpox eradication
Transparency
World Health Organization
China
Smallpox eradication
World Health Organization
China
certification
global health politics
ISSN:1744-1692, 1744-1706, 1744-1706
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Certification is an essential stage in disease eradication efforts, encompassing epidemiological, managerial, and political complexities. The certification of smallpox eradication in the People's Republic of China (PRC, or China) exemplifies the multifaceted nature of the certification. Despite eradicating smallpox in the early 1960s, before the Global Smallpox Eradication Programme (SEP) intensified in 1967, China was one of the last countries certified as smallpox-free by the World Health Organization (WHO) in 1979. The WHO encountered notable resistance during the certification of smallpox eradication in China. This article examines the underlying motivations propelling China's resistance, the factors that contributed to the shifts in its stance, the challenges navigated by the WHO, and the ultimate achievement of certification despite controversies surrounding its transparency and credibility. Through the case of the certification of smallpox eradication, the article provides a historical context of China's selective engagement in global health governance, emphasising the critical importance of building a trusting relationship between the WHO and its member states. It offers insights for fostering effective collaboration among diverse stakeholders driven by varied political agendas in addressing shared global health challenges such as the coronavirus disease (COVID-19) pandemic.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1744-1692
1744-1706
1744-1706
DOI:10.1080/17441692.2024.2326011